Xeris Biopharma Holdings, Inc. XERS

9.10 0.15 1.68% as of 25 Sep
Market cap
$1.6B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
111.04 71.62 72.45 121.97 102.43 133.79 75.55 112.63 42.05 32.27
Receivables
51.05 40.42 39.20 30.83 17.46 6.88 4.69 2.87 1.20 0.10
Inventory
68.67 48.18 38.84 24.74 18.12 8.35 2.18 — — —
Total current assets
240.31 167.66 156.26 186.82 142.60 152.21 87.48 117.90 44.05 33.17
Property, Plant, Equpment (Net)
4.95 5.56 5.97 5.52 6.63 6.71 7.85 2.03 0.79 0.31
Long-Term Investments
— — — 4.35 — — 13.23 — — —
Goodwill and Intangible Assets (Total)
110.94 121.78 132.62 143.47 154.31 — — — — —
Long-term assets (Other)
5.22 5.41 4.54 4.73 0.83 0.23 0.42 0.10 0.16 0.05
Total non-current assets
143.21 155.40 166.34 157.70 161.77 6.94 21.50 2.13 0.95 0.36
Total Assets
383.53 323.06 322.60 344.52 304.36 159.15 108.99 120.03 45.00 33.53
Accounts Payable
3.08 2.29 11.57 4.61 8.92 3.12 5.60 0.87 1.98 1.32
Accrued Expenses
62.22 48.17 36.35 27.99 19.04 8.87 3.33 8.21 2.56 0.90
Current Part of Debt
— 15.10 — 1.58 — — — — — —
Current Revenue (Deferred)
— — — — — — — 0.23 0.23 0.26
Other current liabilities
4.89 1.09 20.28 2.66 1.99 0.32 0.28 1.09 0.09 0.05
Total current liabilities
109.57 100.44 95.19 73.62 79.04 28.21 27.34 10.17 4.86 2.53
Long Term Debt (Total)
220.34 217.01 190.93 187.08 88.07 87.02 58.31 31.89 — —
Non-current Revenue (Deferred)
— — — — 6.88 6.63 7.08 — — 0.04
Long Term Tax Liability (Deferred)
— — 2.27 3.52 4.94 — — — — —
Non-current Liabilities (Other)
8.40 1.97 6.23 25.72 30.20 3.53 1.83 2.56 0.09 0.04
Total non-current liabilities
260.26 252.23 234.19 225.71 130.09 97.18 67.21 34.45 0.09 0.04
Total liabilities
369.84 352.68 329.38 299.34 209.13 125.39 94.55 44.62 4.95 2.57
Additional Paid In Capital
685.00 642.26 610.25 599.97 555.36 371.13 260.64 196.12 2.75 2.10
Preferred Stock (Total)
— — — — — — — — 97.88 62.90
Common Stock (Net)
0.02 0.02 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Retained Earnings
(671.31) (671.86) (617.02) (554.77) (460.11) (337.38) (246.24) (120.66) (60.58) (34.03)
Common Equity (Total)
13.69 (29.61) (6.78) 45.19 95.23 33.76 14.44 75.41 (57.83) (31.93)
Shareholders Equity (Total)
13.69 (29.61) (6.78) 45.19 95.23 33.76 14.44 75.41 40.05 30.96
Shareholders Equity and Liabilities (Total)
383.53 323.06 322.60 344.52 304.36 159.15 108.99 120.03 45.00 33.53
Shares (Common)
166.22 149.43 138.13 136.27 124.87 59.61 27.21 20.81 2.16 1.93
Shares (Preferred)
— — — — — — — 20.38 20.38 14.72
Shareholders Equity (Tangible)
(97.25) (151.39) (139.40) (98.28) (59.08) 33.76 14.44 75.41 40.05 30.96
Net Debt
109.29 160.49 118.48 66.69 (14.37) (46.77) (17.24) (80.74) (42.04) (32.27)
Total Debt
220.34 232.11 190.93 188.66 88.07 87.02 58.31 31.89 — —

Fold the line items

In millions of $ except per-share values · columns are period end dates